Alkem Laboratories Reports 17% Revenue Growth, 22% EBITDA Growth in Q2 FY26
Alkem Laboratories announced a 17% YoY revenue increase to ₹40,010 Mn and a 22% YoY growth in EBITDA to ₹9,208 Mn in Q2 FY26. Domestic sales…
Alkem Laboratories Reports Consolidated Financial Results for Q2 2026
Alkem Laboratories has announced its consolidated financial results for Q2 2026. The company reported a total income of ₹41,046.8 million and…
Ipca Laboratories Q2/H1 FY26 Financial Results Show Strong Growth
Ipca Laboratories announced unaudited financial results for Q2 and H1 FY26. Standalone net total income increased by 7% to ₹1952.24 crores,…
KSB Limited Strong Q2 Results with 5.4% Sales Increase
KSB Limited announced a strong Q2 2025 with sales up 5.4% to ₹649.6 crores. The company secured key contracts, including a ₹53.6 crore export…
Ipca Laboratories Reports Strong Q2 & H1 FY26 Financial Performance
Ipca Laboratories announced a robust financial performance for Q2 and H1 FY26. Standalone Net Total Income increased by 7% to ₹1952.24 crores.…
Granules India Reports Unaudited Standalone and Consolidated Financial Results for Q2 2026
Granules India Limited has announced its unaudited standalone and consolidated financial results for the second quarter and half-year ended…
Vishal Mega Mart Grants 40,25,000 Stock Options to Employees
Vishal Mega Mart has announced the grant of 40,25,000 stock options to its eligible employees and those of its subsidiary. The stock options…
Akzo Nobel India JSW Paints’ Acquisition to Trigger Debenture Trust Deed Obligations
Akzo Nobel India announced it has received notification from JSW Paints regarding the applicability of certain clauses of a debenture trust…
Niva Bupa Insurance Authority Approves Acquisition of 11.53 Crore Equity Shares
Niva Bupa Health Insurance has received approval from the Insurance Regulatory and Development Authority of India (IRDAI) for the proposed…
Bajaj Housing Finance Allotment of Secured NCDs on Private Placement Basis
Bajaj Housing Finance has allotted 50,000 secured redeemable non-convertible debentures (NCDs), with a face value of ₹1,00,000 each,…